Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
7 Results Found
CDC recommends two doses of COVID-19 vaccine for older individuals, lowers pneumococcal vaccine age
The Centers for Disease Control and Prevention last week endorsed a recommendation from the Advisory Committee on Immunization Practices for people aged 65 and older along with individuals moderately or severely immunocompromised to receive a second dose of the 2024-2025 COVID-19 vaccine six months following their first dose.
CMS releases final guidance on hospital respiratory data condition of participation reporting requirements
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition of participation.
FDA authorizes combination tests for flu, COVID-19
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests.
CDC: COVID-19 surging across the U.S.
The Centers for Disease Control COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been since January 2022.
CDC issues advisory on increased parvovirus B19 cases in the U.S.
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S.
CDC encourages older adults to get additional COVID-19 vaccine dose
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25.
FDA: Paxlovid no longer labeled for emergency use after March 8
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced.